Wednesday, August 01, 2018 6:48:09 AM
buyout will come. to get full value company will have to demonstrate rms infusion products work in new market first. this is happening now and will continue. when i read the new ceo resume it is much more investor friendly and consequently rms will get the visibility it deserves. rms has been flying under the radar for a long time and this is about to change
One thing not talked about much is that the rms infusion devices have a superior flow profile. its more even flow rate throughout the infusion. its done at a lower pressure. And generally administered via smaller needle sizes which is important for patient comfort.
nice pop tuesday at end of day. could not find any news
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM